×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
媒體:
189
建立:
2021/01/14
管理者:
系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
搜尋這個資料夾
媒體
(189)
討論區
(0)
常見 Q&A
(0)
知識庫
...
2021年會
摘要
媒體
摘要
摘要
管理者:系統管理者, TUA秘書處, TUA會計採購組, TUA人資客服組, TUA學術會議組, TUA學術資訊組
人氣
討論
發表人
上傳日期
標題
1.
Podium
778
0
TUA人資客服組
2021-05-20
1.1
PD01-1: Safety of darolutamide (DARO) for non-metastatic castration-resistant prostate cancer (nmCRPC) from extended follow-up in the phase III ARAMIS trial
人氣: 778, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
781
0
TUA人資客服組
2021-05-20
1.2
PD01-2: Pelvic Lymph Node Dissection Using Indocyanine Green Fluorescence Lymphangiography in Robotic Assisted Radical Prostatectomy for Non-lymph Node or Distant Metastasis Prostate Cancer Patients.
人氣: 781, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
748
0
TUA人資客服組
2021-05-20
1.3
PD01-3: Association of human polyomavirus, JC and BK virus, infection with prostate cancer in Taiwan
人氣: 748, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
695
0
TUA人資客服組
2021-05-20
1.4
PD01-4: Delayed foley catheter removal after robotic assisted laparoscopic prostatectomy
人氣: 695, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
727
0
TUA人資客服組
2021-05-20
1.5
PD01-5: MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells
人氣: 727, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
712
0
TUA人資客服組
2021-05-20
1.6
PD01-6: Development of a nomogram with combined prostate health index and multiparametric magnetic resonance imaging for predicting extracapsular extension in radical prostatectomy specimens
人氣: 712, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
833
0
TUA人資客服組
2021-05-20
1.7
PD02-1: Fatty liver index is associated with the risk of testosterone deficiency in aging men without metabolic syndrome
人氣: 833, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
783
0
TUA人資客服組
2021-05-20
1.8
PD02-2: MAEL gene expression in testes and ejaculated sperms of infertile men
人氣: 783, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
695
0
TUA人資客服組
2021-05-20
1.9
PD02-3: Assisted reproductive technology outcome in patients with ejaculatory dysfunction using EEJ or needle-TESE
人氣: 695, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
666
0
TUA人資客服組
2021-05-20
1.10
PD02-4: Predictive factors for sperm retrieval rate from male with non-obstructive azoospermia
人氣: 666, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
705
0
TUA人資客服組
2021-05-20
1.11
PD02-5: Intracavernous injection of autologous platelet-rich plasma ameliorated hyperlipidemia-associated erectile dysfunction in a rat model
人氣: 705, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
665
0
TUA人資客服組
2021-05-20
1.12
PD02-6: Clinical profiles and laboratory variables of erectile dysfunction : variation between different age group
人氣: 665, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
701
0
TUA人資客服組
2021-05-20
1.13
PD03-1: Ultrasound guided mini percutaneous nephrolithotomy in galdakao-modified supine valdivia position: Single center experience
人氣: 701, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
675
0
TUA人資客服組
2021-05-20
1.14
PD03-2: Comparison between tubeless mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of 2 to 3cm renal lithiasis
人氣: 675, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
771
0
TUA人資客服組
2021-05-20
1.15
PD03-3: Tubeless, single puncture, mini-percutaneous nephrolithotomy for staghorn stones
人氣: 771, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
737
0
TUA人資客服組
2021-05-20
1.16
PD03-4: Retrograde intrarenal surgery (RIRS) and Endoscopic combined intrarenal surgery (ECIRS) experience for stone management in a single center
人氣: 737, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
778
0
TUA人資客服組
2021-05-20
1.17
PD03-5: Long-term outcome of laparoendoscopic single-site retroperitoneal lumbar sympathectomy for plantar hyperhidrosis
人氣: 778, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
713
0
TUA人資客服組
2021-05-20
1.18
PD03-6: Comparison of outcomes between transperitoneal and retroperitoneal robotic assisted laparoscopic partial nephrectomy
人氣: 713, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
692
0
TUA人資客服組
2021-05-20
1.19
PD04-1: Association between obesity and lower urinary tract symptoms among children and adolescents: A community-based study
人氣: 692, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
764
0
TUA人資客服組
2021-05-20
1.20
PD04-2: Native hydronephrosis after kidney transplantation relates to upper tract urothelial carcinoma: A single center study
人氣: 764, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
794
0
TUA人資客服組
2021-05-20
1.21
PD04-3: Sunitinib related nephrotic syndrome with acute renal failure in patient with renal transplantation: A rare case report
人氣: 794, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
666
0
TUA人資客服組
2021-05-20
1.22
PD04-4: Relationship between Tc-99m diethylene triamine pentaacetic acid renal scan and long term recipient renal function- a-five-year follow up study
人氣: 666, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
682
0
TUA人資客服組
2021-05-20
1.23
PD04-5: Evaluate the effect of oligo-fucoidan prevent renal fibrosis on a mouse model of unilateral ureter obstruction
人氣: 682, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
671
0
TUA人資客服組
2021-05-20
1.24
PD04-6: Prothymosin α/HOTAIR signaling axis regulates cachexia in bladder cancer patients during cisplatin chemotherapy in an EGFR-dependent manner
人氣: 671, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
761
0
TUA人資客服組
2021-05-20
1.25
PD05-1: A new classification of detrusor underactivity based on videourodynamic characteristics in men.
人氣: 761, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
745
0
TUA人資客服組
2021-05-20
1.26
PD05-2: Effect of nocturia in patients with different severity of obstructive sleep apnea on polysomnography
人氣: 745, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
632
0
TUA人資客服組
2021-05-20
1.27
PD05-3: Interleukin-27/ Interleukin-27 receptor α subunit signaling may modulate inflammation and progression of benign prostatic hyperplasia via suppressing the LPS/TLR4 pathway
人氣: 632, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
754
0
TUA人資客服組
2021-05-20
1.28
PD05-4: Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo
人氣: 754, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
694
0
TUA人資客服組
2021-05-20
1.29
PD05-5: Improvement of cell proliferation, cytoskeleton and barrier function protein expression after platelet-rich plasma injection suggests improved urothelial health in the patients with intractable recurrent urinary tract infection
人氣: 694, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
784
0
TUA人資客服組
2021-05-20
1.30
PD05-6: Factors predicting mortality in patients with fournier’s gangrene
人氣: 784, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
711
0
TUA人資客服組
2021-05-20
1.31
PD06-1: Glycine tomentella hayata extract and its ingredient daidzin ameliorate cyclophosphamide‑induced hemorrhagic cystitis and oxidative stress through the action of antioxidation, anti‑fibrosis, and anti‑inflammation
人氣: 711, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
708
0
TUA人資客服組
2021-05-20
1.32
PD06-2: The change of pressure-flow study parameters in patients before and after robot-assisted laparoscopic radical prostatectomy
人氣: 708, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
680
0
TUA人資客服組
2021-05-20
1.33
PD06-3: Urethral sphincter injection of platelet-rich plasma in treatment of female stress urinary incontinence
人氣: 680, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
743
0
TUA人資客服組
2021-05-20
1.34
PD06-4: Therapeutic efficacy and cognitive adverse events of OAB medication on patients with CNS lesion
人氣: 743, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
954
0
TUA人資客服組
2021-05-20
1.35
PD06-5: Can the focal bladder wall thickness predict pathophysiology and treatment outcome in the patients with ulcer and non-ulcer type interstitial cystitis?
人氣: 954, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
655
0
TUA人資客服組
2021-05-20
1.36
PD06-6: External validation of solomon-greenwell nomogram for diagnosing female bladder outlet obstruction
人氣: 655, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
689
0
TUA人資客服組
2021-05-20
1.37
PD07-1: Automated differentiation of benign and malignant renal tumors on computed tomography using artificial intelligence
人氣: 689, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
782
0
TUA人資客服組
2021-05-20
1.38
PD07-2: The mTOR pathway expression of three types of renal angiomyolipoma
人氣: 782, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
658
0
TUA人資客服組
2021-05-20
1.39
PD07-3: Tumor characteristics and survival outcomes of renal cell carcinoma during the past decade in Taiwanese population: A dual-center retrospective study
人氣: 658, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
900
0
TUA人資客服組
2021-05-20
1.40
PD07-4: Hsa-mir-34a, as a novel autophagy regulator, inhibits STX-17-mediated fusion of autophagosomes with lysosomes
人氣: 900, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
666
0
TUA人資客服組
2021-05-20
1.41
PD07-5: Retrospective analysis of Hepatocellular carcinoma with adrenal metastasis treatment and prognosis – VGTCH experience
人氣: 666, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
821
0
TUA人資客服組
2021-05-20
1.42
PD07-6: Experience with modified Makuuchi incision in the surgical treatment for huge retroperitoneal tumor
人氣: 821, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-20
945
0
TUA人資客服組
2021-05-24
1.43
PD08-1: Can ERBT take place of the importance of traditional TURBt?
人氣: 945, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
871
0
TUA人資客服組
2021-05-24
1.44
PD08-2: Treatment outcome and FGFR alteration rate in unresectable locally advanced or metastatic urothelial cancer in Taiwan
人氣: 871, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
664
0
TUA人資客服組
2021-05-24
1.45
PD08-3: Long non-coding RNA mediates cisplatin and gemcitabine resistance in upper tract urothelial carcinoma cells by sponging of miR-31
人氣: 664, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
832
0
TUA人資客服組
2021-05-24
1.46
PD08-4: Partial cystectomy after neoadjuvant chemotherapy for muscle invasive bladder cancer
人氣: 832, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
619
0
TUA人資客服組
2021-05-24
1.47
PD08-5: miR-375 suppresses upper tract urothelial carcinoma cell migration and invasion via targeting Derlin-1
人氣: 619, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
692
0
TUA人資客服組
2021-05-24
1.48
PD08-6: Immune checkpoint biomarker on circulating tumor cells as a potential predictor of therapeutic efficacy in urothelial carcinoma patients
人氣: 692, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
2.
Moderated Poster
755
0
TUA人資客服組
2021-05-24
2.1
MP01-01: The risk factors analysis for the biochemical failure within two years for patients with PSA failure after robotic radical prostatectomy
人氣: 755, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
870
0
TUA人資客服組
2021-05-24
2.2
MP01-02: The efficacy of the adjustable male sling system for stress urinary incontinence after radical prostatectomy
人氣: 870, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
761
0
TUA人資客服組
2021-05-24
2.3
MP01-03: Transperineal ultrasound magnetic resonance imaging fusion biopsy combined transrectal ultrasound systemic biopsy for prostate cancer detection – A single center experience
人氣: 761, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
894
0
TUA人資客服組
2021-05-24
2.4
MP01-04: Optimizing the biopsy strategy of MRI/US fusion transperineal prostate biopsy: saturation target biopsy
人氣: 894, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
781
0
TUA人資客服組
2021-05-24
2.5
MP01-05: The prognostic utility of FBLN2 expression in patients with urothelial carcinoma
人氣: 781, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
679
0
TUA人資客服組
2021-05-24
2.6
MP01-06: The association between Ki-67 expression and characteristics of prostate cancer
人氣: 679, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
713
0
TUA人資客服組
2021-05-24
2.7
MP01-07: Cabazitaxel improves clinical outcomes in patients with metastatic castration-resistant prostate cancer
人氣: 713, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
695
0
TUA人資客服組
2021-05-24
2.8
MP01-08: The association between androgen deprivation therapy and the risk of thyroid diseases
人氣: 695, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
783
0
TUA人資客服組
2021-05-24
2.9
MP01-09: Outcome of patients with low to intermediate risk prostate cancer receiving radical prostatectomy – A single center experience
人氣: 783, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
700
0
TUA人資客服組
2021-05-24
2.10
MP01-10: Anti-cancer effect of rutin in human prostate cancer cell
人氣: 700, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
730
0
TUA人資客服組
2021-05-24
2.11
MP02-01: Prediction of microdissection testicular sperm extraction outcome in post-chemotherapy azoospermic men using cyclophosphamide equivalent dose
人氣: 730, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
750
0
TUA人資客服組
2021-05-24
2.12
MP02-02: Improvement of erectile dysfunction and lower urinary tract symptoms in men with surgical correction of sleep apnea
人氣: 750, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
631
0
TUA人資客服組
2021-05-24
2.13
MP02-03: Low intensity extracorporeal shockwave therapy improves the resistance index of Cavernosal artery especially in those patients with poor pre-treatment resistance index
人氣: 631, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
652
0
TUA人資客服組
2021-05-24
2.14
MP02-04: Association of age with video-urodynamic studies findings in women presenting weak steam symptoms
人氣: 652, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
626
0
TUA人資客服組
2021-05-24
2.15
MP02-05: Is coiled embolization justified for treating patient with veno-occlusive dysfunction: a case report and systemic review?
人氣: 626, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
707
0
TUA人資客服組
2021-05-24
2.16
MP02-06: The eight fibro-ligament structure in the human penis
人氣: 707, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
824
0
TUA人資客服組
2021-05-24
2.17
MP02-07: Juniperus communis protects against hemorrhagic shock-induced acute kidney injury in conscious mice
人氣: 824, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
698
0
TUA人資客服組
2021-05-24
2.18
MP02-08: The clinical experiences of urine metabolomics of genitourinary urothelial cancer in a tertiary hospital in Taiwan
人氣: 698, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
664
0
TUA人資客服組
2021-05-24
2.19
MP02-09: Trend of life expectancy of patients for radical prostatectomy of prostate cancer in Taiwan—2020 update
人氣: 664, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
758
0
TUA人資客服組
2021-05-24
2.20
MP02-10: Does urinary tract infection impact the performance of fully automated urine chemistry analyzer uc-3500 in detecting albuminuria?
人氣: 758, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
671
0
TUA人資客服組
2021-05-24
2.21
MP03-01: Long term outcomes of endoscopic management of upper urinary tract urethelial carcinoma(UTUC) in Taiwan UTUC registry
人氣: 671, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
634
0
TUA人資客服組
2021-05-24
2.22
MP03-02: Synergistic effect of intravesical instillation of chidamide and mitomycin C treatment through Axl signaling in genotoxic carcinogen–induced bladder cancer
人氣: 634, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
589
0
TUA人資客服組
2021-05-24
2.23
MP03-03: Real world experience of metastatic urothelial carcinoma treated with immune check point inhibitors
人氣: 589, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
770
0
TUA人資客服組
2021-05-24
2.24
MP03-04: Autophagy inhibitor increased-PD-L1 expression suppress the effect of antitumor immunity in bladder cancer
人氣: 770, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
599
0
TUA人資客服組
2021-05-24
2.25
MP03-05: Overexpression of nucleobindin-2(NUCB2) in upper tract urothelial carcinoma
人氣: 599, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
766
0
TUA人資客服組
2021-05-24
2.26
MP03-06: Intravesical instillation of azacitidine suppresses tumor formation through TNF-R1 and TRAIL-R2 signaling in genotoxic carcinogen–induced bladder cancer
人氣: 766, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
784
0
TUA人資客服組
2021-05-24
2.27
MP03-07: Association risk of smoking on overall and specific mortality of patients with bladder cancer: A population-based study
人氣: 784, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
577
0
TUA人資客服組
2021-05-24
2.28
MP03-08: Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles
人氣: 577, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
775
0
TUA人資客服組
2021-05-24
2.29
MP03-09: Effect of nephroureterectomy on circulating tumor cells in patients with upper urinary tract urothelial carcinoma
人氣: 775, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
831
0
TUA人資客服組
2021-05-24
2.30
MP03-10: Overexpression of Src is associated with worse prognosis and harbored the potential as a therapeutic target in urothelial carcinoma
人氣: 831, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
634
0
TUA人資客服組
2021-05-24
2.31
MP04-01: High urinary crystal volume suggests hypercalciuria in the calcium stone formers
人氣: 634, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
671
0
TUA人資客服組
2021-05-24
2.32
MP04-02: Retrograde intrarenal surgery for renal stone: initial experience
人氣: 671, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
576
0
TUA人資客服組
2021-05-24
2.33
MP04-03: Fluoroless retroperitoneoscopic ureterolithotomy with simultaneous retrograde intrarenal surgery for renal stone extraction in the Galdakao-modified supine Valdivia position
人氣: 576, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
606
0
TUA人資客服組
2021-05-24
2.34
MP04-04: Thep tubeless percutaneous nephrolithotomy (pcnl) : the experience of Taichung Tzu Chi Hospital
人氣: 606, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
607
0
TUA人資客服組
2021-05-24
2.35
MP04-05: The alteration of urinary protein after SWL in the patients with nephrolithiasis
人氣: 607, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
669
0
TUA人資客服組
2021-05-24
2.36
MP04-06: The association between phthalate levels in urine and urinary uric acid
人氣: 669, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
560
0
TUA人資客服組
2021-05-24
2.37
MP04-07: Obesity-related indices and its association with kidney stone
人氣: 560, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
609
0
TUA人資客服組
2021-05-24
2.38
MP04-08: The effect of uric acid on the calcium oxalate crystallization
人氣: 609, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
732
0
TUA人資客服組
2021-05-24
2.39
MP04-09: The role of PRP injection in the prophylaxis of recurrent UTI in women-any predictive factor?
人氣: 732, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
778
0
TUA人資客服組
2021-05-24
2.40
MP04-10: Strangulated urethral prolapse occurring in a patient being treated for central precocious puberty
人氣: 778, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
612
0
TUA人資客服組
2021-05-24
2.41
MP05-01: The prognostic impact of tumour architecture for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis
人氣: 612, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
571
0
TUA人資客服組
2021-05-24
2.42
MP05-02: PR-619, an inhibitor of deubiquitylating enzymes, reverses drug resistance in cisplatin-resistant urothelial carcinoma cells via suppression of c-myc
人氣: 571, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
785
0
TUA人資客服組
2021-05-24
2.43
MP05-03: Small non-coding microRNAs (miRNAs) target hepatoma-derived growth factor (HDGF) as a novel therapeutic strategy for urothelial carcinoma
人氣: 785, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
644
0
TUA人資客服組
2021-05-24
2.44
MP05-04: The attenuation of chloroquine and hydroxychloroquine on the invasive potential of bladder cancer by targeting MMP-2 expression
人氣: 644, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
704
0
TUA人資客服組
2021-05-24
2.45
MP05-05: Cadherin-11 regulates cell pyroptosis and induces anti-tumor immunity through PD-L1 in bladder cancer
人氣: 704, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
579
0
TUA人資客服組
2021-05-24
2.46
MP05-06: External validation of Likert scale for predicting non-muscle invasive bladder cancer, KCGMH experience
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
645
0
TUA人資客服組
2021-05-24
2.47
MP05-07: Hyperthermia inhibits chemotherapeutic drug resistance of bladder cancer cells through epithelial mesenchymal transition down-regulation
人氣: 645, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
645
0
TUA人資客服組
2021-05-24
2.48
MP05-08: Anti-cancer effects and tumor marker role of glutathione s-transferase mu 5 in human bladder cancer
人氣: 645, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
653
0
TUA人資客服組
2021-05-24
2.49
MP05-09: Glutathione s-transferase Mu 5 plays anti-tumor activity in bladder cancer cells
人氣: 653, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
909
0
TUA人資客服組
2021-05-24
2.50
MP05-10: Results of bevacizumab plus erlotinib in patients with metastatic type 2 papillary renal cell cancer - experience in Taipei Veterans General Hospital
人氣: 909, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
673
0
TUA人資客服組
2021-05-24
2.51
MP06-01: Impact of obesity on the outcome of prostate cancer post robot-assisted radical prostatectomy
人氣: 673, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
871
0
TUA人資客服組
2021-05-24
2.52
MP06-02: The senhance robotic system is feasible in oncologic and non-oncologic urologic surgeries: initial experiences and troubleshooting of new system
人氣: 871, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
657
0
TUA人資客服組
2021-05-24
2.53
MP06-03: Routine use of prophylactic metoclopramide after transperitoneal robotic-assisted radical prostatectomy: really needed?
人氣: 657, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
631
0
TUA人資客服組
2021-05-24
2.54
MP06-04: Urethra-sphincter complex volume predictive of residual diverticulum after diverticulectomy
人氣: 631, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
641
0
TUA人資客服組
2021-05-24
2.55
MP06-05: The video urodynamic characteristics in SCI patients with different injury level and bladder condition
人氣: 641, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
569
0
TUA人資客服組
2021-05-24
2.56
MP06-06: Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse
人氣: 569, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
635
0
TUA人資客服組
2021-05-24
2.57
MP06-07: XX male syndrome : A rare cause of male infertility, case analysis in a tertiary fertility service
人氣: 635, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
584
0
TUA人資客服組
2021-05-24
2.58
MP06-08: Serum vitamin D levels in females with urinary incontinence: a meta-analysis of observational trials
人氣: 584, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
617
0
TUA人資客服組
2021-05-24
2.59
MP06-09: Anal sphincter length and power are associated with early continent after radical prostatectomy
人氣: 617, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
654
0
TUA人資客服組
2021-05-24
2.60
MP06-10: Perioperative Outcomes of Robotic Assisted Radical Prostatectomy in Elder Patients
人氣: 654, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
572
0
TUA人資客服組
2021-05-24
2.61
MP07-01: Difference of electron microscopic findings in IC/BPS with different cystoscopic characteristics following hydrodistention
人氣: 572, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
629
0
TUA人資客服組
2021-05-24
2.62
MP07-02: The impact of androgen deprivation therapy on lower urinary tract symptoms in prostate cancer patients - a single institute experience
人氣: 629, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
656
0
TUA人資客服組
2021-05-24
2.63
MP07-03: The role of Aptamers in regulation of prostate inflammatory process
人氣: 656, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
590
0
TUA人資客服組
2021-05-24
2.64
MP07-04: Post-Operative Change of PSA as an Outcome Predictor in BPH Patients Receiving Transurethral Laser Surgery
人氣: 590, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
639
0
TUA人資客服組
2021-05-24
2.65
MP07-05: Comparison of Thulium laser (VelaTM XL) enucleation of prostate with bipolar transurethral enucleation of the prostate (B-TUEP) of outcome and quality of life
人氣: 639, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
605
0
TUA人資客服組
2021-05-24
2.66
MP07-06: Risk factors for highly recurrent bladder neck contracture after transurethral resection/enucleation of prostate for benign prostate hyperplasia
人氣: 605, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
608
0
TUA人資客服組
2021-05-24
2.67
MP07-07: Study on the pathophysiological mechanism responsible for lower urinary tract symptoms associated with prostate cancer using an animal model
人氣: 608, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
999
0
TUA人資客服組
2021-05-24
2.68
MP07-08: The safety and efficacy of greenlight laser(XPS) for the treatment of prostate beyond 100gm
人氣: 999, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
619
0
TUA人資客服組
2021-05-24
2.69
MP07-09: Risk factors for transient urge urinary incontinence after transurethral procedures in the treatment of benign prostatic hyperplasia
人氣: 619, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
542
0
TUA人資客服組
2021-05-24
2.70
MP07-10: Correlation between Chronic prostatitis/Chronic pelvic pain syndrome and other prostatic disease in population-base study using Taiwan National Health Insurance Research Database
人氣: 542, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
3.
Non-Discussion Poster
686
0
TUA人資客服組
2021-05-24
3.1
NDP001: IgG4 related disease from renal pelvis mimicking urothelial carcinoma: A case report
人氣: 686, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
645
0
TUA人資客服組
2021-05-24
3.2
NDP002: Immunotherapy for fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC): Three cases report
人氣: 645, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
744
0
TUA人資客服組
2021-05-24
3.3
NDP003: Fifteen-year-follow-up of adrenal cyst mimicking malignancy: A case report
人氣: 744, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
803
0
TUA人資客服組
2021-05-24
3.4
NDP004: A rare of retroperitoneal low-grade B‐cell lymphoma associated with paraneoplastic pemphigus and bronchiolitis of lung disease
人氣: 803, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
646
0
TUA人資客服組
2021-05-24
3.5
NDP005: Case report: Pembrolizumab treatment in metastatic urothelial carcinoma with underlying disease of autoimmune disease
人氣: 646, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
570
0
TUA人資客服組
2021-05-24
3.6
NDP006: Rare presentation of renal angiomyolipoma: Aggressive behavior with perinephric extension and inferior vena cava invasion
人氣: 570, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
616
0
TUA人資客服組
2021-05-24
3.7
NDP007: Immune checkpoint inhibitor therapy-associated kidney graft intolerance in a patient with metastatic urothelial carcinoma
人氣: 616, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
593
0
TUA人資客服組
2021-05-24
3.8
NDP008: Metastatic papillary renal cell carcinoma without primary renal tumor: treatment experience and follow up
人氣: 593, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
593
0
TUA人資客服組
2021-05-24
3.9
NDP009: Metastatic INI1-deficient and succinate dehydrogenase B-deficient renal cell carcinoma treated with presurgical Pembolizumab/Axitinib followed by consolidative nephrectomy: a case report
人氣: 593, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
591
0
TUA人資客服組
2021-05-24
3.10
NDP010: Chondroma of the urinary bladder: A case report
人氣: 591, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
636
0
TUA人資客服組
2021-05-24
3.11
NDP011: Retroperitoneal mucinous cystadenoma with neuroendocrine features: a case report and review of the literature
人氣: 636, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
595
0
TUA人資客服組
2021-05-24
3.12
NDP012: Cases Report: Huge cystic non-clear cell renal cell carcinoma with duodenum, ascending and transverse colon invasion associated with peritonitis
人氣: 595, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
638
0
TUA人資客服組
2021-05-24
3.13
NDP013: IgG4-related disease with ureteropelvic junction tumor: A case report
人氣: 638, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
689
0
TUA人資客服組
2021-05-24
3.14
NDP014: Rare renal tumor: MiT family translocation renal cell carcinoma
人氣: 689, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
571
0
TUA人資客服組
2021-05-24
3.15
NDP015: Primary small cell neuroendocrine carcinoma of the urinary bladder: Case report and review of the literature
人氣: 571, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
718
0
TUA人資客服組
2021-05-24
3.16
NDP016: Radium-223 injection for more then 3 courses improves survival in patients with metastatic castration-resistant prostate cancer
人氣: 718, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
626
0
TUA人資客服組
2021-05-24
3.17
NDP017: A real-world experience of using Abiraterone acetate in the treatment of metastatic castration sensitive prostate cancer
人氣: 626, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
570
0
TUA人資客服組
2021-05-24
3.18
NDP018: Rare primary large-cell neuroendocrine carcinoma of the urinary bladder: A case report and literature review
人氣: 570, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
606
0
TUA人資客服組
2021-05-24
3.19
NDP019: Hyperglycemia and risk of progression to castration-resistance in men with metastatic hormone sensitive prostate cancer
人氣: 606, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
592
0
TUA人資客服組
2021-05-24
3.20
NDP020: Ureteroenteric fistula after hemicolectomy: A case report
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
623
0
TUA人資客服組
2021-05-24
3.21
NDP021: A case report: Retroperitoneal angiomyolipoma with malignant progression to dedifferentiated liposarcoma
人氣: 623, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
561
0
TUA人資客服組
2021-05-24
3.22
NDP022: Bladder urothelial carcinoma with plasmacytoid variant: A case report
人氣: 561, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
623
0
TUA人資客服組
2021-05-24
3.23
NDP023: Different appearance of multiple angiomyolipoma in the same kidney of patient in computed tomography image: case report and literature review
人氣: 623, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
606
0
TUA人資客服組
2021-05-24
3.24
NDP024: Accidental finding of myxofibrosarcoma of the spermatic cord during inguinal hernia surgery
人氣: 606, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
666
0
TUA人資客服組
2021-05-24
3.25
NDP025: A case report: A huge adrenal myelolipoma
人氣: 666, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
570
0
TUA人資客服組
2021-05-24
3.26
NDP026: Castleman's disease in the pelvis: A case report
人氣: 570, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
599
0
TUA人資客服組
2021-05-24
3.27
NDP027: Primary mucinous adenocarcinoma of urinary bladder: A case report and literature review
人氣: 599, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
621
0
TUA人資客服組
2021-05-24
3.28
NDP028: Large cell neuroendocrine carcinoma of bladder: A case report
人氣: 621, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
616
0
TUA人資客服組
2021-05-24
3.29
NDP029: Bladder carcinoma presenting with rectal obstruction
人氣: 616, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
624
0
TUA人資客服組
2021-05-24
3.30
NDP030: Cystic nephroma masquerading as renal cell carcinoma: A case report and review of literature
人氣: 624, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
579
0
TUA人資客服組
2021-05-24
3.31
NDP031: Rare paratesticular aggressive angiomyxoma mimicking an epididymal tumor in an 82-year-old man: One case report
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
602
0
TUA人資客服組
2021-05-24
3.32
NDP032: A huge retroperitoneal liposarcoma in HIV patient with renal displacement
人氣: 602, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
683
0
TUA人資客服組
2021-05-24
3.33
NDP033: Radium-223 for mCRPC: Real-world experience of a single-center
人氣: 683, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
669
0
TUA人資客服組
2021-05-24
3.34
NDP034: Submucosal bladder leiomyoma - A case report
人氣: 669, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
604
0
TUA人資客服組
2021-05-24
3.35
NDP035: Small cell carcinoma of the urinary bladder: A case report and literature review
人氣: 604, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
735
0
TUA人資客服組
2021-05-24
3.36
NDP036: The diagnostic value of prostate cancer between transrectal ultrasound guided prostate biopsy and transurethral resection of the prostate: A retrospective comparative study
人氣: 735, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
560
0
TUA人資客服組
2021-05-24
3.37
NDP037: Lower urinary tract symptoms caused by Müllerian duct cyst: A case report
人氣: 560, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
611
0
TUA人資客服組
2021-05-24
3.38
NDP038: A Igg4-related retroperitoneal fibrosis presenting with bilateral severe hydronephrosis
人氣: 611, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
592
0
TUA人資客服組
2021-05-24
3.39
NDP039: Case report: Transurethra resection of intravesical ureterocele and literature review
人氣: 592, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
597
0
TUA人資客服組
2021-05-24
3.40
NDP040: Special treatment for severe ureteral stones impaction
人氣: 597, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
680
0
TUA人資客服組
2021-05-24
3.41
NDP041: Domino effect of left upper moiety giant hydronephrosis with compression to inferior vena cava induce syncope
人氣: 680, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
663
0
TUA人資客服組
2021-05-24
3.42
NDP042: Rare complication of common endoscopic cystolitholapaxy with unilateral diagnostic ureteroscopy: a case report
人氣: 663, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
637
0
TUA人資客服組
2021-05-24
3.43
NDP043: Case report: Bilateral horseshoe kidney stones treated by retrograde intrarenal surgery and literature review
人氣: 637, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
810
0
TUA人資客服組
2021-05-24
3.44
NDP044: Case report: Flexible ureteroscopy (fURS) for N-type and reverse N-type kinking ureter caused by stone obstruction
人氣: 810, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
645
0
TUA人資客服組
2021-05-24
3.45
NDP045: Retrieval of intrarenal foreign body from ruptured guidewire by retrograde intrarenal surgery: A case report and literature review
人氣: 645, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
626
0
TUA人資客服組
2021-05-24
3.46
NDP046: Retrograde intrarenal surgery for huge ureteral stones at Y junction of bifid ureter: A case report and literature review
人氣: 626, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
717
0
TUA人資客服組
2021-05-24
3.47
NDP047: Case report: bladder tamponade induced by submucosal aneurysm bleeding resulted from bladder stone
人氣: 717, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
665
0
TUA人資客服組
2021-05-24
3.48
NDP048: Case report: : Laparoscopic nephropexy: The sliding clip technique
人氣: 665, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
579
0
TUA人資客服組
2021-05-24
3.49
NDP049: Concomitant usage of ureter and urethra catheters facilitate overcoming post partial nephrectomy urine leakage
人氣: 579, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
653
0
TUA人資客服組
2021-05-24
3.50
NDP050: Symptomatic lymphoceles present as deep vein thrombosis following robot‑assisted laparoscopic radical prostatectomy and pelvic lymph node dissection: A case report
人氣: 653, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
636
0
TUA人資客服組
2021-05-24
3.51
NDP051: Congenital bilateral absence of the vas deferens (CBAVD) with bilaterally present seminal vesicles
人氣: 636, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
738
0
TUA人資客服組
2021-05-24
3.52
NDP052: A rare penile fracture with a deep rupture over crus of penis in a patient with orchiectomy: A case report
人氣: 738, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
622
0
TUA人資客服組
2021-05-24
3.53
NDP053: Adult spinal bifida presenting with lower urinary tract dysfunction only: A case report
人氣: 622, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
706
0
TUA人資客服組
2021-05-24
3.54
NDP054: Prolapsed ureterocele causing bladder outlet obstruction: A case report and literature review
人氣: 706, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
586
0
TUA人資客服組
2021-05-24
3.55
NDP055: Concurrent urachal abscess and florid cystitis glandularis masquerading as malignancy: A case report and literature review
人氣: 586, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
658
0
TUA人資客服組
2021-05-24
3.56
NDP056: Neisseria meningitidis: A rare pathogen of urethritis in young man
人氣: 658, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
580
0
TUA人資客服組
2021-05-24
3.57
NDP057: An unusual Presentation of a 8 cm Xanthogranulomatous cyst
人氣: 580, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
641
0
TUA人資客服組
2021-05-24
3.58
NDP058: Nontyphoidal salmonella emphysematous pyelonephritis and necrotizing fasciitis: A case report and review of the literature
人氣: 641, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
567
0
TUA人資客服組
2021-05-24
3.59
NDP059: Vasitis: A clinical confusion diagnosis with inguinal hernia
人氣: 567, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
687
0
TUA人資客服組
2021-05-24
3.60
NDP060: Initial experience of apply of disposable circumcision suture device to children-7case sharing
人氣: 687, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
663
0
TUA人資客服組
2021-05-24
3.61
NDP061: Case report: Zinner syndrome in adolescent with chronic severe perineal pain
人氣: 663, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
566
0
TUA人資客服組
2021-05-24
3.62
NDP062: Ex Vivo treatment of stones in donor kidney by retrograde intrarenal surgery: A case report and review of the literature
人氣: 566, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
584
0
TUA人資客服組
2021-05-24
3.63
NDP063: Postoperative adrenal insufficiency in a case with co-secretion of aldosterone and cortisone adrenal adenoma
人氣: 584, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
629
0
TUA人資客服組
2021-05-24
3.64
NDP064: The validity and reliability of the instrument of the gender-sensitive waiting space(gswsi) in urological out patient department
人氣: 629, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
643
0
TUA人資客服組
2021-05-24
3.65
NDP065: Recurrent tumor causing aorto-enteric fistula: A rare presentation of upper tract urothelial carcinoma
人氣: 643, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
608
0
TUA人資客服組
2021-05-24
3.66
NDP066: Lleal ureter substitution used yang-monti principle in ureteral injury repair: 2 cases report
人氣: 608, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
772
0
TUA人資客服組
2021-05-24
3.67
NDP067: Extraperitoneal laparoscopic repair of huge inguinoscrotal bladder hernia: A case report and literature review
人氣: 772, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
690
0
TUA人資客服組
2021-05-24
3.68
NDP068: A case of adhesion duodenum mimicking an atrophic kidney with hydronephrosis
人氣: 690, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
732
0
TUA人資客服組
2021-05-24
3.69
NDP069: Cauda equina syndrome with urinary retention as a postoperative complication of lumbar spine surgery
人氣: 732, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
819
0
TUA人資客服組
2021-05-24
3.70
NDP070: A combination of Xanthogranulomatous prostatitis and benign prostate hyperplasia: A rare case report
人氣: 819, 討論: 0, 發表人: TUA人資客服組, 上傳時間: 2021-05-24
848
0
TUA會計採購組
2021-12-09
3.71
NDP071: The role and clinical value of POLR2A, RUNX2, and micro-RNA378 in sarcomatoid renal cell carcinoma
人氣: 848, 討論: 0, 發表人: TUA會計採購組, 上傳時間: 2021-12-09